The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $3,443.72 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1C testing. The delivery order, which does not have a set-aside designation, calls for Tosoh Bioscience to provide cost per test A1C testing services through September 30, 2021 for VISN 23,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $3,366.30 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1C testing services. Performance will take place in South San Francisco, California through August 2020. As part of its mission to provide quality healthcare to America's veterans, VHA uses this type of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $6,286.70 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The delivery order, which does not contain a set-aside designation, calls for Tosoh Bioscience to provide cost-per-test A1c testing through September 30, 2022 to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $26,044.48 firm fixed price delivery order to Tosoh Bioscience, Inc. (doing business as Tosoh USA) on October 1, 2022 for A1C LAB services. The order, which utilizes no set-aside designation and has a completion date of September 30, 2023, will provide laboratory testing support to assist VHA 23 in evaluating and monitoring care for veterans with diabetes. Tosoh Bioscience will...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $10,023.44 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The contract has a period of performance through August 22, 2020 to support the VA's clinical care and health monitoring programs. Tosoh USA will provide HbA1c testing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc. a $2,058 firm fixed price delivery order against an Indefinite Delivery Indefinite Quantity Cost Per Test Hemoglobin A1c Testing contract. Tosoh Bioscience, Inc. will provide hemoglobin A1c testing services to support the VA's efforts to monitor and manage diabetes for veterans in the South San Francisco, California area under the order, which has a period of...
Tosoh Bioscience, Inc., doing business as Tosoh USA, has been awarded a $608 firm fixed price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 Indefinite Delivery Indefinite Quantity Cost Per Test Hemoglobin A1c Testing contract. This delivery order calls for Tosoh Bioscience to provide Hemoglobin A1c testing services for VISN 23, which oversees VA medical facilities in parts of California and Nevada, in support of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, a $10,405.64 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1C) testing services. The contract has a period of performance through August 2024 and calls for Tosoh Bioscience to provide cost-per-test HbA1c testing to support the care of veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded Tosoh Bioscience, Inc., doing business as Tosoh USA, an $11,676.70 firm fixed price delivery order against an indefinite-delivery, indefinite-quantity contract for glycated hemoglobin A1c (HbA1c or A1c) testing services. The delivery order, which does not have a set-aside designation, calls for Tosoh Bioscience to provide cost-per-test A1c testing through September 30, 2022 to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an Indefinite Delivery Indefinite Quantity Cost Per Test contract to Tosoh Bioscience, Inc. for Hemoglobin A1c testing services. Under this $11,500.30 potential value delivery order, Tosoh Bioscience will provide Hemoglobin A1c testing to support VHA's efforts to monitor blood glucose levels in patients with diabetes. Performance will take place in South San Francisco, California...